The Cxbladder Rule-out of Recurrent Urothelial Carcinoma

UnknownOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

November 26, 2018

Primary Completion Date

August 31, 2019

Study Completion Date

November 30, 2020

Conditions
Bladder Cancer
Interventions
DIAGNOSTIC_TEST

Cx bladder Monitor test

Cxbladder Monitor is a non-invasive UC detection test measuring five messenger RNA (mRNA) biomarkers present at elevated levels in patients presenting with urothelial carcinoma and also two clinical variables (whether the previous tumor was primary or recurrent and the time since the previous tumor was resected).

Trial Locations (1)

N6A 5W9

RECRUITING

Victoria Hospital, London

Sponsors
All Listed Sponsors
collaborator

Pacific Edge Limited

INDUSTRY

lead

London Health Sciences Centre

OTHER